PIUS EHIANE: Open Payments
NPI 1962801951 · NORTH LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 59 payments from 9 companies in 2025. Trend: 2023 $848 · 2024 $1,012 · 2025 $1,272
Food & beverage: $1,272
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $275 |
| Alkermes, Inc. | 10 | $273 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $245 |
| Otsuka America Pharmaceutical, Inc. | 11 | $235 |
| Janssen Pharmaceuticals, Inc | 3 | $88 |
| ABBVIE INC. | 3 | $68 |
| Lundbeck LLC | 3 | $46 |
| Bausch Health US, LLC | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: COBENFY, ARISTADA, REXULTI, CAPLYTA, VRAYLAR, INVEGA SUSTENNA, SPRAVATO, APLENZIN.
Industry payments across NV — which companies pay providers there.
